• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年非小细胞肺癌复发患者的治疗选择模式及预后因素:一项观察性研究

Treatment selection pattern and prognostic factors in older patients with non-small cell lung cancer at recurrence: an observational study.

作者信息

Sonoda Dai, Maruyama Raito, Kondo Yasuto, Naito Masahito, Mikubo Masashi, Shiomi Kazu, Satoh Yukitoshi

机构信息

Department of Thoracic Surgery, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-Ku, Sagamihara, Kanagawa, 252-0374, Japan.

Department of Thoracic Surgery, Kitasato University Medical Center, 6-100 Arai, Kitamoto, Saitama, 364-08501, Japan.

出版信息

Surg Today. 2025 Apr;55(4):588-599. doi: 10.1007/s00595-024-02938-3. Epub 2024 Sep 27.

DOI:10.1007/s00595-024-02938-3
PMID:39331121
Abstract

PURPOSE

Society is aging, and the proportion of older patients with lung cancer is increasing. However, the treatment choices and prognoses for older patients with cancer recurrence remain unclear. We retrospectively investigated the treatment choices and prognoses of older patients with recurrence.

METHODS

We conducted a retrospective review of 1100 patients who underwent complete resection for non-small cell lung cancer at Kitasato University Hospital between 2004 and 2017. Patients of ≥75 years of age were defined as older patients, and the prognosis and prognostic factors of these patients upon recurrence were examined.

RESULTS

Among the 290 patients who developed recurrence, 106 experienced recurrence at an older age. The factors associated with survival after recurrence included sex, time to recurrence, number of recurrences, performance status at recurrence, and active treatment. As the age at recurrence increased, the proportion of patients who did not receive active treatment increased, as did the proportion for whom the reason was the patient's and family's preferences.

CONCLUSIONS

A considerable number of older patients who experience recurrence do not wish to receive active treatment. However, the prognosis can be improved by aggressive treatment for recurrence.

摘要

目的

社会正在老龄化,老年肺癌患者的比例在增加。然而,癌症复发的老年患者的治疗选择和预后仍不明确。我们回顾性研究了老年复发患者的治疗选择和预后。

方法

我们对2004年至2017年期间在北里大学医院接受非小细胞肺癌完全切除术的1100例患者进行了回顾性研究。年龄≥75岁的患者被定义为老年患者,并对这些患者复发后的预后和预后因素进行了检查。

结果

在290例出现复发的患者中,106例在老年时复发。复发后生存相关因素包括性别、复发时间、复发次数、复发时的体能状态和积极治疗。随着复发年龄的增加,未接受积极治疗的患者比例增加,因患者及其家属意愿而未接受积极治疗的比例也增加。

结论

相当数量的复发老年患者不希望接受积极治疗。然而,对复发进行积极治疗可以改善预后。

相似文献

1
Treatment selection pattern and prognostic factors in older patients with non-small cell lung cancer at recurrence: an observational study.老年非小细胞肺癌复发患者的治疗选择模式及预后因素:一项观察性研究
Surg Today. 2025 Apr;55(4):588-599. doi: 10.1007/s00595-024-02938-3. Epub 2024 Sep 27.
2
Prognostic factors for return to work in breast cancer survivors.乳腺癌幸存者恢复工作的预后因素。
Cochrane Database Syst Rev. 2025 May 7;5(5):CD015124. doi: 10.1002/14651858.CD015124.pub2.
3
[Joint analysis of invasive margins and tumor center to evaluate the prognostic value of bystander CD8 T cells in early-stage non-small cell lung cancer].[联合分析浸润边缘和肿瘤中心以评估旁观者CD8 T细胞在早期非小细胞肺癌中的预后价值]
Zhonghua Zhong Liu Za Zhi. 2025 Jun 23;47(6):508-516. doi: 10.3760/cma.j.cn112152-20240805-00326.
4
Predicting the risk of subsequent progression in patients with systemic sclerosis-associated interstitial lung disease with progression: a multicentre observational cohort study.预测系统性硬化症相关间质性肺病进展患者后续病情进展的风险:一项多中心观察性队列研究。
Lancet Rheumatol. 2025 Jul;7(7):e463-e471. doi: 10.1016/S2665-9913(25)00026-8. Epub 2025 May 14.
5
Aural toilet (ear cleaning) for chronic suppurative otitis media.慢性化脓性中耳炎的耳道清理(耳部清洁)
Cochrane Database Syst Rev. 2025 Jun 9;6(6):CD013057. doi: 10.1002/14651858.CD013057.pub3.
6
Hospital Volume and Social Determinants of Health Do Not Impact Outcomes in Fenestrated Visceral Segment Endovascular Aortic Repair for Patients Treated at VQI Centers.医院手术量和健康的社会决定因素对在VQI中心接受治疗的患者进行开窗内脏段血管腔内主动脉修复术的预后没有影响。
Vasc Endovascular Surg. 2025 Aug;59(6):584-593. doi: 10.1177/15385744251330017. Epub 2025 Mar 24.
7
Prognostic Implications of Lymph Node Status in Non-Small-Cell Lung Cancer Patients Before and After Neoadjuvant Chemoimmunotherapy: A Multicenter Retrospective Study.新辅助化疗免疫治疗前后非小细胞肺癌患者淋巴结状态的预后意义:一项多中心回顾性研究
Clin Lung Cancer. 2025 Jul;26(5):370-383. doi: 10.1016/j.cllc.2025.04.004. Epub 2025 Apr 8.
8
A Randomized Trial of Nutrition and Exercise Treatment in Patients With Pancreatic and Non-Small Cell Lung Cancer (NEXTAC-TWO).胰腺癌和非小细胞肺癌患者营养与运动治疗的随机试验(NEXTAC-TWO)
J Cachexia Sarcopenia Muscle. 2025 Jun;16(3):e13871. doi: 10.1002/jcsm.13871.
9
Does Undertreatment With Chemotherapy Impact the Outcomes of Elderly Patients With Early-Stage Breast Cancer? A Real-World Data Analysis.化疗治疗不足是否会影响老年早期乳腺癌患者的预后?一项真实世界数据分析。
Clin Breast Cancer. 2025 Jul;25(5):472-480.e3. doi: 10.1016/j.clbc.2025.02.007. Epub 2025 Feb 18.
10
Toripalimab plus bevacizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma (HEPATORCH): a randomised, open-label, phase 3 trial.托法替布联合贝伐珠单抗对比索拉非尼作为晚期肝细胞癌一线治疗的疗效(HEPATORCH):一项随机、开放标签的3期试验
Lancet Gastroenterol Hepatol. 2025 Jul;10(7):658-670. doi: 10.1016/S2468-1253(25)00059-7. Epub 2025 May 20.

本文引用的文献

1
Physical Activity and Cognitive Decline Among Older Adults: A Systematic Review and Meta-Analysis.老年人的体力活动与认知能力下降:系统评价和荟萃分析。
JAMA Netw Open. 2024 Feb 5;7(2):e2354285. doi: 10.1001/jamanetworkopen.2023.54285.
2
Optimal Treatment Strategy for Oligo-Recurrence Lung Cancer Patients with Driver Mutations.驱动基因突变的寡转移复发性肺癌患者的最佳治疗策略
Cancers (Basel). 2024 Jan 22;16(2):464. doi: 10.3390/cancers16020464.
3
First-line nivolumab plus ipilimumab with or without chemotherapy for Japanese patients with non-small cell lung cancer: LIGHT-NING study.
一线纳武利尤单抗联合伊匹单抗加或不加化疗治疗日本非小细胞肺癌患者:LIGHT-NING 研究。
Jpn J Clin Oncol. 2024 Apr 6;54(4):452-462. doi: 10.1093/jjco/hyad195.
4
Prognosis of patients with recurrent nonsmall cell lung cancer who received the best supportive care alone.仅接受最佳支持治疗的复发性非小细胞肺癌患者的预后
Curr Probl Surg. 2024 Jan;61(1):101429. doi: 10.1016/j.cpsurg.2023.101429. Epub 2023 Nov 25.
5
Empirical Analysis of Preferences of Older Adults for Care Facilities in Japan: Focusing on Household Structure and Economic Status.日本老年人对护理设施偏好的实证分析:以家庭结构和经济状况为重点。
Healthcare (Basel). 2023 Jun 25;11(13):1843. doi: 10.3390/healthcare11131843.
6
Perioperative outcomes of robotic-assisted versus video-assisted thoracoscopic lobectomy: A propensity score matched analysis.机器人辅助与电视辅助胸腔镜肺叶切除术的围手术期结果:倾向评分匹配分析。
Thorac Cancer. 2023 Jul;14(20):1921-1931. doi: 10.1111/1759-7714.14938. Epub 2023 May 18.
7
Epidermal growth factor receptor tyrosine kinase inhibitors as first-line treatment for postoperative recurrent EGFR-mutated lung adenocarcinoma: a multi-institutional retrospective study.表皮生长因子受体酪氨酸激酶抑制剂作为术后复发 EGFR 突变型肺腺癌的一线治疗:一项多机构回顾性研究。
Eur J Cardiothorac Surg. 2022 Oct 4;62(5). doi: 10.1093/ejcts/ezac430.
8
Efficacy and safety of immune checkpoint inhibitor monotherapy in pretreated elderly patients with non-small cell lung cancer.免疫检查点抑制剂单药治疗预处理老年非小细胞肺癌患者的疗效和安全性。
Cancer Chemother Pharmacol. 2020 Apr;85(4):761-771. doi: 10.1007/s00280-020-04055-7. Epub 2020 Mar 19.
9
Comparison of Carboplatin Plus Pemetrexed Followed by Maintenance Pemetrexed With Docetaxel Monotherapy in Elderly Patients With Advanced Nonsquamous Non-Small Cell Lung Cancer: A Phase 3 Randomized Clinical Trial.卡铂联合培美曲塞治疗后序贯培美曲塞维持治疗对比多西他赛单药治疗老年晚期非鳞状非小细胞肺癌患者:一项 3 期随机临床试验。
JAMA Oncol. 2020 May 1;6(5):e196828. doi: 10.1001/jamaoncol.2019.6828. Epub 2020 May 14.
10
The clinical features of older patients with lung cancer in comparison with their younger counterparts.老年肺癌患者与年轻肺癌患者相比的临床特征。
Respir Investig. 2019 Jan;57(1):40-48. doi: 10.1016/j.resinv.2018.10.003. Epub 2018 Nov 15.